Rhode Island Bladder Cancer Resources – Bladder Cancer Advocacy Network

English Español

Donate

Return to Map

State of Rhode Island Department of Health
http://health.ri.gov/

Contact Your State Elected Representative

http://ri.gov/government/?tags=elected+officials

Bladder Cancer Cases in Rhode Island at a Glance

340

New State Cases
82,290

New National
Cases
62,420

National Cases in Men
19,870

National Cases in Women
16,710

National Deaths

Veterans Administration Hospitals

Providence VA Medical Center

Bladder Cancer Clinical Trials in Rhode Island

LOXO-435 in Patients With Cancer With a Change in a Gene Called FGFR3 A Study of TAR-200 in Combination With Cetrelimab and Cetrelimab Alone in Participants With Muscle-Invasive Urothelial Carcinoma of the Bladder Erdafitinib in Participants With Metastatic or Locally Advanced Urothelial Cancer Continued Access Study for Participants Deriving Benefit in Pfizer-Sponsored Avelumab Parent Studies That Are Closing UGN-301 in Patients With Recurrent Non-muscle Invasive Bladder Cancer (NMIBC)

See more clinical trials